Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) has seen significant options activity, with over 16 transactions valued at $427,360, focusing on a price band between $880.0 and $905.0. The stock's current price is $894.58, with a 0.24% increase and an RSI indicating it may be approaching oversold territory. Analyst ratings in the last 30 days have set an average price target of $1033.6, with varying recommendations from Buy to Neutral. The next earnings report is expected in 2 days.
April 30, 2024 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals sees active options trading and analyst interest, with a near-term focus on its upcoming earnings report and current stock price movement.
The significant options activity, combined with the upcoming earnings report and recent analyst ratings, suggests a heightened interest in REGN's short-term price movement. The stock's slight increase and the RSI hint at potential volatility, making it a focal point for investors. The average analyst price target above the current price indicates a bullish outlook, potentially influencing short-term investor sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100